Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PTP4A1 as a therapeutic target for fibrotic diseases and disorders including systemic sclerosis

PTP4A1 as a therapeutic target for fibrotic diseases and disorders including systemic sclerosis

US Patent 11331388 · Granted May 17, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunoregulatory microparticles for modulating inflammatory arthritides2025
Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof2022
Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof2022
Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof2020
Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof2020
Modulation of PTPRA to treat arthritis2020
Modulation of PTPRA to treat arthritis2020
Autoimmune disease treatments2019
Autoimmune disease treatments2019
Method for monitoring intracellular tyrosine phosphatase activity2013
Method for monitoring intracellular tyrosine phosphatase activity2013
Methods and compositions for acid phosphatase-1 gene inhibition2011